Clinical Trials Logo

Clinical Trial Summary

Type 2 diabetes is a major problem of public health in the French West Indies, with an estimated prevalence of 8%, twice more than in France. In Guadeloupe, according to the statistical data of hospital morbidity in 2004, 2643 hospital stays were diagnosed with diabetes. These cases mainly concerned woman (62%) and the elderly, from 45 to 74 years old (67%).

The main objective of this research is to describe the insulin protocol used in Guadeloupe for treated type 2 diabetes patients and their characteristics:

- The duration of the type 2 diabetes

- Time elapsing between the diagnosis and the treatment by insulin

- Where the follow up care took place

- Existence of complications

Secondary objectives were to describe the link between the HbA1c rate and the insulin therapy protocol. And also to present the main inconveniences expressed by patients and their degree of autonomy.


Clinical Trial Description

Nowadays the set up for insulin treatment is available in general practitioners' offices. However, it is restrained by the reticence of patients and physicians. For type 2 diabetes, insulin therapy is well managed and there is ongoing progress. But there are still some questions about the effect of the treatment in the everyday life of patients: culture, fear, material resources, necessity of education.

Ignorance and prejudices on insulin injection are still prevalent and often it delays for more than a year the time when patients have to switch an insulin treatment for unbalanced chronic disorder.

Type 2 diabetes patients think that the treatment is heavy, can lead to serious hypoglycemia, is uncomfortable for family and can cause fear.

Education of the patients can reduce ignorance and prejudices about insulin treatment.

Nowadays studies show that diabetes patients want to be more involved in the decisions linked to their treatment which impact their perception of the disease and the treatment.

Auto measurement of glycaemia can help the patient better manage his disease and make him understand the importance of controlling his glycaemia levels.

This study could allow to:

- Offer a new care organization for a better use of resources (network, patient therapeutic education…)

- Set up adequate training for professionals and for patients being cared for in medical offices.

- Improve the glycemic balance of patients and slower the growth of degenerative complications. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03362762
Study type Observational
Source Centre Hospitalier Universitaire de Pointe-a-Pitre
Contact
Status Completed
Phase N/A
Start date December 16, 2013
Completion date September 27, 2016

See also
  Status Clinical Trial Phase
Completed NCT04522882 - Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1 N/A
Completed NCT04274660 - Evaluation of Diabetes and WELLbeing Programme N/A
Not yet recruiting NCT05185518 - Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes N/A
Recruiting NCT05893797 - A Study of LY8888AX in Participants Using a Connected Insulin Management Platform N/A
Completed NCT02791295 - Lifestyle Intervention in Type 2 Diabetes N/A
Withdrawn NCT04957173 - Intensive Lifestyle Intervention in Patients With Insulin-treated Type 2 Diabetes: a Pilot Project N/A
Completed NCT05372471 - Efficacy of the Digital Platform for Diabetes Care Compared to Usual Care in Patients Diagnosed With Type 2 Diabetes. N/A
Completed NCT05111301 - Control-IQ Technology in Individuals With Type 2 Diabetes N/A
Recruiting NCT04585191 - Reducing Treatment Risk in Older Adults With Diabetes N/A
Recruiting NCT04871438 - Flash CONtinous Glucose Monitoring in TRansition to Outpatient: Libre for Type 2 Diabetes Mellitus (CONTROL-DM) N/A
Completed NCT06060743 - Examining the Effect of Mobile Application on Insulin Use Perception and Self-Management N/A
Completed NCT04005261 - C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes
Terminated NCT03980236 - Feasibility of Using the Livongo-Insulia Study App for Patients With Type 2 Diabetes [Pilot Study] N/A
Not yet recruiting NCT06185296 - The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy N/A
Completed NCT03437525 - Peer Support in Diabetes Management - Insulin Peer Support N/A
Active, not recruiting NCT03070106 - Diabetes: Functional Medicine Approach vs. Usual Care N/A
Completed NCT02060916 - Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes Phase 2
Recruiting NCT05785832 - A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes N/A
Recruiting NCT04945070 - INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi Phase 4
Recruiting NCT05795439 - The CARING Study: Creating and Restoring Health Through Nutrition Guidance N/A